SlideShare una empresa de Scribd logo
1 de 3
Descargar para leer sin conexión
Global Immunoassay Systems Market 2012 - 2016
Description:
TechNavio's analysts forecast the Global Immunoassay Systems market to grow at a CAGR of 3.92 percent
over the period 2012-2016. One of the key factors contributing to this market growth is the increased
prevalence of chronic diseases worldwide. The Global Immunoassay Systems market has also been witnessing
a growing popularity of portable immunoassays. However, limited reimbursements could pose a challenge to
the growth of this market.
TechNavio's report, the Global Immunoassay Systems market 2012-2016, has been prepared based on an
in-depth market analysis with inputs from industry experts. The report covers the Global Immunoassay
Systems market in the Americas, the EMEA, and the APAC regions, its market landscape, and growth
prospects in the coming years. The report also includes a discussion of the key vendors operating in this
market.
The key vendors dominating this market space include Abbott Laboratories, Danaher Corp., Roche Holding
Ltd., and Siemens Healthcare Diagnostics Inc.
The other vendors mentioned in the report are BioMerieux SA, BiOptic Inc., Bio-Rad Laboratories Inc.,
Fujirebio Inc., Johnson and Johnson, PerkinElmer Inc., and Trinity Biotech plc.
Key questions answered in this report:
What will the market size be in 2015 and what will be the growth rate? What are key market trends? What is
driving this market? What are the challenges to market growth? Who are the key vendors in this market space?
What are the market opportunities and threats faced by key vendors? What are the strengths and weaknesses of
each of these key vendors?
table Of Contents:
1. Executive Summary
2. List Of Abbreviations
3. Introduction
4. Research Methodology
market Research Process
research Design
research Methodology
Global Immunoassay Systems Market 2012 - 2016
5. Scope Of The Report
market Overview
product Offerings
6. Market Landscape
6.1 Global Immunoassay Systems Market
market Size And Forecast
6.2 Market Segmentation
enzyme Immunoassay Systems
fluorescence Immunoassay Systems
chemiluminescence Immunoassay Systems
radio Immunoassay Systems
nephelometric Immunoassay Systems
6.3 Global Enzyme Immunoassay Systems Market
market Size And Forecast
6.4 Five Forces Analysis
7. Geographical Segmentation
8. Vendor Landscape
9. Buying Criteria
10. Market Growth Drivers
11. Drivers And Their Impact
12. Market Challenges
13. Impact Of Drivers And Challenges
14. Market Trends
Global Immunoassay Systems Market 2012 - 2016
15. Key Vendor Analysis
15.1 Abbott Laboratories
business Overview
key Information
swot Analysis
15.2 Danaher Corp.
business Overview
key Information
swot Analysis
15.3 Roche Holding Ltd.
business Overview
key Information
swot Analysis
15.4 Siemens Healthcare Diagnostics Inc.
business Overview
key Information
swot Analysis
16. Other Reports In This Series
ResearchMoz(http://www.researchmoz.us/) is the one stop online destination to find and buy market research
reports & Industry Analysis. We fulfill all your research needs spanning across industry verticals with our
huge collection of market research reports. We provide our services to all sizes of organizations and across all
industry verticals and markets. Our Research Coordinators have in-depth knowledge of reports as well as
publishers and will assist you in making an informed decision by giving you unbiased and deep insights on
which reports will satisfy your needs at the best price.
Contact:
M/s Sheela,
90 State Street,
Suite 700,
Albany NY - 12207
United States
Tel: +1-518-618-1030
USA - Canada Toll Free 866-997-4948
Email: sales@researchmoz.us
Website: http://www.researchmoz.us/
Global Immunoassay Systems Market 2012 - 2016

Más contenido relacionado

Más de Ambikabasa

Ocular pain pipeline review, h1 2015
Ocular pain   pipeline review, h1 2015Ocular pain   pipeline review, h1 2015
Ocular pain pipeline review, h1 2015Ambikabasa
 
Paroxysmal nocturnal hemoglobinuria pipeline review, h1 2015
Paroxysmal nocturnal hemoglobinuria   pipeline review, h1 2015Paroxysmal nocturnal hemoglobinuria   pipeline review, h1 2015
Paroxysmal nocturnal hemoglobinuria pipeline review, h1 2015Ambikabasa
 
Rhabdomyosarcoma pipeline review, h1 2015
Rhabdomyosarcoma   pipeline review, h1 2015Rhabdomyosarcoma   pipeline review, h1 2015
Rhabdomyosarcoma pipeline review, h1 2015Ambikabasa
 
Raynauds disease pipeline review, h1 2015
Raynauds disease   pipeline review, h1 2015Raynauds disease   pipeline review, h1 2015
Raynauds disease pipeline review, h1 2015Ambikabasa
 
Travelers diarrhea pipeline review, h1 2015
Travelers diarrhea   pipeline review, h1 2015Travelers diarrhea   pipeline review, h1 2015
Travelers diarrhea pipeline review, h1 2015Ambikabasa
 
Herpes zoster (shingles) pipeline review, h1 2015
Herpes zoster (shingles)   pipeline review, h1 2015Herpes zoster (shingles)   pipeline review, h1 2015
Herpes zoster (shingles) pipeline review, h1 2015Ambikabasa
 
Emphysema pipeline review, h1 2015
Emphysema   pipeline review, h1 2015Emphysema   pipeline review, h1 2015
Emphysema pipeline review, h1 2015Ambikabasa
 
Cerebral infarction (brain infarction) pipeline review, h1 2015
Cerebral infarction (brain infarction)   pipeline review, h1 2015Cerebral infarction (brain infarction)   pipeline review, h1 2015
Cerebral infarction (brain infarction) pipeline review, h1 2015Ambikabasa
 
Seborrhea pipeline review, h1 2015
Seborrhea   pipeline review, h1 2015Seborrhea   pipeline review, h1 2015
Seborrhea pipeline review, h1 2015Ambikabasa
 
Respiratory depression pipeline review, h1 2015
Respiratory depression   pipeline review, h1 2015Respiratory depression   pipeline review, h1 2015
Respiratory depression pipeline review, h1 2015Ambikabasa
 
H1 n1 infection pipeline review, h1 2015
H1 n1 infection   pipeline review, h1 2015H1 n1 infection   pipeline review, h1 2015
H1 n1 infection pipeline review, h1 2015Ambikabasa
 
Nicotine addiction pipeline review, h1 2015
Nicotine addiction   pipeline review, h1 2015Nicotine addiction   pipeline review, h1 2015
Nicotine addiction pipeline review, h1 2015Ambikabasa
 
Food allergy pipeline review, h1 2015
Food allergy   pipeline review, h1 2015Food allergy   pipeline review, h1 2015
Food allergy pipeline review, h1 2015Ambikabasa
 
Uveal melanoma pipeline review, h1 2015
Uveal melanoma   pipeline review, h1 2015Uveal melanoma   pipeline review, h1 2015
Uveal melanoma pipeline review, h1 2015Ambikabasa
 
Tillotts pharma ag product pipeline review - 2015
Tillotts pharma ag   product pipeline review - 2015Tillotts pharma ag   product pipeline review - 2015
Tillotts pharma ag product pipeline review - 2015Ambikabasa
 
Co mentis, inc. product pipeline review - 2015
Co mentis, inc.   product pipeline review - 2015Co mentis, inc.   product pipeline review - 2015
Co mentis, inc. product pipeline review - 2015Ambikabasa
 
Therapure biopharma inc. product pipeline review - 2015
Therapure biopharma inc.   product pipeline review - 2015Therapure biopharma inc.   product pipeline review - 2015
Therapure biopharma inc. product pipeline review - 2015Ambikabasa
 
Genzyme corporation product pipeline review - 2015
Genzyme corporation   product pipeline review - 2015Genzyme corporation   product pipeline review - 2015
Genzyme corporation product pipeline review - 2015Ambikabasa
 
Quantum genomics sa product pipeline review - 2015
Quantum genomics sa   product pipeline review - 2015Quantum genomics sa   product pipeline review - 2015
Quantum genomics sa product pipeline review - 2015Ambikabasa
 
Brain cancer pipeline review, h1 2015
Brain cancer   pipeline review, h1 2015Brain cancer   pipeline review, h1 2015
Brain cancer pipeline review, h1 2015Ambikabasa
 

Más de Ambikabasa (20)

Ocular pain pipeline review, h1 2015
Ocular pain   pipeline review, h1 2015Ocular pain   pipeline review, h1 2015
Ocular pain pipeline review, h1 2015
 
Paroxysmal nocturnal hemoglobinuria pipeline review, h1 2015
Paroxysmal nocturnal hemoglobinuria   pipeline review, h1 2015Paroxysmal nocturnal hemoglobinuria   pipeline review, h1 2015
Paroxysmal nocturnal hemoglobinuria pipeline review, h1 2015
 
Rhabdomyosarcoma pipeline review, h1 2015
Rhabdomyosarcoma   pipeline review, h1 2015Rhabdomyosarcoma   pipeline review, h1 2015
Rhabdomyosarcoma pipeline review, h1 2015
 
Raynauds disease pipeline review, h1 2015
Raynauds disease   pipeline review, h1 2015Raynauds disease   pipeline review, h1 2015
Raynauds disease pipeline review, h1 2015
 
Travelers diarrhea pipeline review, h1 2015
Travelers diarrhea   pipeline review, h1 2015Travelers diarrhea   pipeline review, h1 2015
Travelers diarrhea pipeline review, h1 2015
 
Herpes zoster (shingles) pipeline review, h1 2015
Herpes zoster (shingles)   pipeline review, h1 2015Herpes zoster (shingles)   pipeline review, h1 2015
Herpes zoster (shingles) pipeline review, h1 2015
 
Emphysema pipeline review, h1 2015
Emphysema   pipeline review, h1 2015Emphysema   pipeline review, h1 2015
Emphysema pipeline review, h1 2015
 
Cerebral infarction (brain infarction) pipeline review, h1 2015
Cerebral infarction (brain infarction)   pipeline review, h1 2015Cerebral infarction (brain infarction)   pipeline review, h1 2015
Cerebral infarction (brain infarction) pipeline review, h1 2015
 
Seborrhea pipeline review, h1 2015
Seborrhea   pipeline review, h1 2015Seborrhea   pipeline review, h1 2015
Seborrhea pipeline review, h1 2015
 
Respiratory depression pipeline review, h1 2015
Respiratory depression   pipeline review, h1 2015Respiratory depression   pipeline review, h1 2015
Respiratory depression pipeline review, h1 2015
 
H1 n1 infection pipeline review, h1 2015
H1 n1 infection   pipeline review, h1 2015H1 n1 infection   pipeline review, h1 2015
H1 n1 infection pipeline review, h1 2015
 
Nicotine addiction pipeline review, h1 2015
Nicotine addiction   pipeline review, h1 2015Nicotine addiction   pipeline review, h1 2015
Nicotine addiction pipeline review, h1 2015
 
Food allergy pipeline review, h1 2015
Food allergy   pipeline review, h1 2015Food allergy   pipeline review, h1 2015
Food allergy pipeline review, h1 2015
 
Uveal melanoma pipeline review, h1 2015
Uveal melanoma   pipeline review, h1 2015Uveal melanoma   pipeline review, h1 2015
Uveal melanoma pipeline review, h1 2015
 
Tillotts pharma ag product pipeline review - 2015
Tillotts pharma ag   product pipeline review - 2015Tillotts pharma ag   product pipeline review - 2015
Tillotts pharma ag product pipeline review - 2015
 
Co mentis, inc. product pipeline review - 2015
Co mentis, inc.   product pipeline review - 2015Co mentis, inc.   product pipeline review - 2015
Co mentis, inc. product pipeline review - 2015
 
Therapure biopharma inc. product pipeline review - 2015
Therapure biopharma inc.   product pipeline review - 2015Therapure biopharma inc.   product pipeline review - 2015
Therapure biopharma inc. product pipeline review - 2015
 
Genzyme corporation product pipeline review - 2015
Genzyme corporation   product pipeline review - 2015Genzyme corporation   product pipeline review - 2015
Genzyme corporation product pipeline review - 2015
 
Quantum genomics sa product pipeline review - 2015
Quantum genomics sa   product pipeline review - 2015Quantum genomics sa   product pipeline review - 2015
Quantum genomics sa product pipeline review - 2015
 
Brain cancer pipeline review, h1 2015
Brain cancer   pipeline review, h1 2015Brain cancer   pipeline review, h1 2015
Brain cancer pipeline review, h1 2015
 

Último

wagamamaLab presentation @MIT 20240509 IRODORI
wagamamaLab presentation @MIT 20240509 IRODORIwagamamaLab presentation @MIT 20240509 IRODORI
wagamamaLab presentation @MIT 20240509 IRODORIIRODORI inc.
 
How to refresh to be fit for the future world
How to refresh to be fit for the future worldHow to refresh to be fit for the future world
How to refresh to be fit for the future worldChris Skinner
 
Global Internal Audit Standards 2024.pdf
Global Internal Audit Standards 2024.pdfGlobal Internal Audit Standards 2024.pdf
Global Internal Audit Standards 2024.pdfAmer Morgan
 
1Q24_EN hyundai capital 1q performance
1Q24_EN   hyundai capital 1q performance1Q24_EN   hyundai capital 1q performance
1Q24_EN hyundai capital 1q performanceirhcs
 
zidauu _business communication.pptx /pdf
zidauu _business  communication.pptx /pdfzidauu _business  communication.pptx /pdf
zidauu _business communication.pptx /pdfzukhrafshabbir
 
PitchBook’s Guide to VC Funding for Startups
PitchBook’s Guide to VC Funding for StartupsPitchBook’s Guide to VC Funding for Startups
PitchBook’s Guide to VC Funding for StartupsAlejandro Cremades
 
Hyundai capital 2024 1q Earnings release
Hyundai capital 2024 1q Earnings releaseHyundai capital 2024 1q Earnings release
Hyundai capital 2024 1q Earnings releaseirhcs
 
Expert Cross-Border Financial Planning Advisors
Expert Cross-Border Financial Planning AdvisorsExpert Cross-Border Financial Planning Advisors
Expert Cross-Border Financial Planning Advisorscardinalpointwealth11
 
Potato Flakes Manufacturing Plant Project Report.pdf
Potato Flakes Manufacturing Plant Project Report.pdfPotato Flakes Manufacturing Plant Project Report.pdf
Potato Flakes Manufacturing Plant Project Report.pdfhostl9518
 
Raising Seed Capital by Steve Schlafman at RRE Ventures
Raising Seed Capital by Steve Schlafman at RRE VenturesRaising Seed Capital by Steve Schlafman at RRE Ventures
Raising Seed Capital by Steve Schlafman at RRE VenturesAlejandro Cremades
 
Future of Trade 2024 - Decoupled and Reconfigured - Snapshot Report
Future of Trade 2024 - Decoupled and Reconfigured - Snapshot ReportFuture of Trade 2024 - Decoupled and Reconfigured - Snapshot Report
Future of Trade 2024 - Decoupled and Reconfigured - Snapshot ReportDubai Multi Commodity Centre
 
A Brief Introduction About Jacob Badgett
A Brief Introduction About Jacob BadgettA Brief Introduction About Jacob Badgett
A Brief Introduction About Jacob BadgettJacobBadgett
 
tekAura | Desktop Procedure Template (2016)
tekAura | Desktop Procedure Template (2016)tekAura | Desktop Procedure Template (2016)
tekAura | Desktop Procedure Template (2016)Norah Medlin
 
hyundai capital 2023 consolidated financial statements
hyundai capital 2023 consolidated financial statementshyundai capital 2023 consolidated financial statements
hyundai capital 2023 consolidated financial statementsirhcs
 
NFS- Operations Presentation - Recurrent
NFS- Operations Presentation - RecurrentNFS- Operations Presentation - Recurrent
NFS- Operations Presentation - Recurrenttoniquemcintosh1
 
Stages of Startup Funding - An Explainer
Stages of Startup Funding - An ExplainerStages of Startup Funding - An Explainer
Stages of Startup Funding - An ExplainerAlejandro Cremades
 
Series A Fundraising Guide (Investing Individuals Improving Our World) by Accion
Series A Fundraising Guide (Investing Individuals Improving Our World) by AccionSeries A Fundraising Guide (Investing Individuals Improving Our World) by Accion
Series A Fundraising Guide (Investing Individuals Improving Our World) by AccionAlejandro Cremades
 
TriStar Gold Corporate Presentation May 2024
TriStar Gold Corporate Presentation May 2024TriStar Gold Corporate Presentation May 2024
TriStar Gold Corporate Presentation May 2024Adnet Communications
 
LinkedIn Masterclass Techweek 2024 v4.1.pptx
LinkedIn Masterclass Techweek 2024 v4.1.pptxLinkedIn Masterclass Techweek 2024 v4.1.pptx
LinkedIn Masterclass Techweek 2024 v4.1.pptxSymbio Agency Ltd
 
Blinkit: Revolutionizing the On-Demand Grocery Delivery Service.pptx
Blinkit: Revolutionizing the On-Demand Grocery Delivery Service.pptxBlinkit: Revolutionizing the On-Demand Grocery Delivery Service.pptx
Blinkit: Revolutionizing the On-Demand Grocery Delivery Service.pptxSaksham Gupta
 

Último (20)

wagamamaLab presentation @MIT 20240509 IRODORI
wagamamaLab presentation @MIT 20240509 IRODORIwagamamaLab presentation @MIT 20240509 IRODORI
wagamamaLab presentation @MIT 20240509 IRODORI
 
How to refresh to be fit for the future world
How to refresh to be fit for the future worldHow to refresh to be fit for the future world
How to refresh to be fit for the future world
 
Global Internal Audit Standards 2024.pdf
Global Internal Audit Standards 2024.pdfGlobal Internal Audit Standards 2024.pdf
Global Internal Audit Standards 2024.pdf
 
1Q24_EN hyundai capital 1q performance
1Q24_EN   hyundai capital 1q performance1Q24_EN   hyundai capital 1q performance
1Q24_EN hyundai capital 1q performance
 
zidauu _business communication.pptx /pdf
zidauu _business  communication.pptx /pdfzidauu _business  communication.pptx /pdf
zidauu _business communication.pptx /pdf
 
PitchBook’s Guide to VC Funding for Startups
PitchBook’s Guide to VC Funding for StartupsPitchBook’s Guide to VC Funding for Startups
PitchBook’s Guide to VC Funding for Startups
 
Hyundai capital 2024 1q Earnings release
Hyundai capital 2024 1q Earnings releaseHyundai capital 2024 1q Earnings release
Hyundai capital 2024 1q Earnings release
 
Expert Cross-Border Financial Planning Advisors
Expert Cross-Border Financial Planning AdvisorsExpert Cross-Border Financial Planning Advisors
Expert Cross-Border Financial Planning Advisors
 
Potato Flakes Manufacturing Plant Project Report.pdf
Potato Flakes Manufacturing Plant Project Report.pdfPotato Flakes Manufacturing Plant Project Report.pdf
Potato Flakes Manufacturing Plant Project Report.pdf
 
Raising Seed Capital by Steve Schlafman at RRE Ventures
Raising Seed Capital by Steve Schlafman at RRE VenturesRaising Seed Capital by Steve Schlafman at RRE Ventures
Raising Seed Capital by Steve Schlafman at RRE Ventures
 
Future of Trade 2024 - Decoupled and Reconfigured - Snapshot Report
Future of Trade 2024 - Decoupled and Reconfigured - Snapshot ReportFuture of Trade 2024 - Decoupled and Reconfigured - Snapshot Report
Future of Trade 2024 - Decoupled and Reconfigured - Snapshot Report
 
A Brief Introduction About Jacob Badgett
A Brief Introduction About Jacob BadgettA Brief Introduction About Jacob Badgett
A Brief Introduction About Jacob Badgett
 
tekAura | Desktop Procedure Template (2016)
tekAura | Desktop Procedure Template (2016)tekAura | Desktop Procedure Template (2016)
tekAura | Desktop Procedure Template (2016)
 
hyundai capital 2023 consolidated financial statements
hyundai capital 2023 consolidated financial statementshyundai capital 2023 consolidated financial statements
hyundai capital 2023 consolidated financial statements
 
NFS- Operations Presentation - Recurrent
NFS- Operations Presentation - RecurrentNFS- Operations Presentation - Recurrent
NFS- Operations Presentation - Recurrent
 
Stages of Startup Funding - An Explainer
Stages of Startup Funding - An ExplainerStages of Startup Funding - An Explainer
Stages of Startup Funding - An Explainer
 
Series A Fundraising Guide (Investing Individuals Improving Our World) by Accion
Series A Fundraising Guide (Investing Individuals Improving Our World) by AccionSeries A Fundraising Guide (Investing Individuals Improving Our World) by Accion
Series A Fundraising Guide (Investing Individuals Improving Our World) by Accion
 
TriStar Gold Corporate Presentation May 2024
TriStar Gold Corporate Presentation May 2024TriStar Gold Corporate Presentation May 2024
TriStar Gold Corporate Presentation May 2024
 
LinkedIn Masterclass Techweek 2024 v4.1.pptx
LinkedIn Masterclass Techweek 2024 v4.1.pptxLinkedIn Masterclass Techweek 2024 v4.1.pptx
LinkedIn Masterclass Techweek 2024 v4.1.pptx
 
Blinkit: Revolutionizing the On-Demand Grocery Delivery Service.pptx
Blinkit: Revolutionizing the On-Demand Grocery Delivery Service.pptxBlinkit: Revolutionizing the On-Demand Grocery Delivery Service.pptx
Blinkit: Revolutionizing the On-Demand Grocery Delivery Service.pptx
 

Global Immunoassay Systems Market Size 2012 - 2016 | Researchmoz.us

  • 1. Global Immunoassay Systems Market 2012 - 2016 Description: TechNavio's analysts forecast the Global Immunoassay Systems market to grow at a CAGR of 3.92 percent over the period 2012-2016. One of the key factors contributing to this market growth is the increased prevalence of chronic diseases worldwide. The Global Immunoassay Systems market has also been witnessing a growing popularity of portable immunoassays. However, limited reimbursements could pose a challenge to the growth of this market. TechNavio's report, the Global Immunoassay Systems market 2012-2016, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the Global Immunoassay Systems market in the Americas, the EMEA, and the APAC regions, its market landscape, and growth prospects in the coming years. The report also includes a discussion of the key vendors operating in this market. The key vendors dominating this market space include Abbott Laboratories, Danaher Corp., Roche Holding Ltd., and Siemens Healthcare Diagnostics Inc. The other vendors mentioned in the report are BioMerieux SA, BiOptic Inc., Bio-Rad Laboratories Inc., Fujirebio Inc., Johnson and Johnson, PerkinElmer Inc., and Trinity Biotech plc. Key questions answered in this report: What will the market size be in 2015 and what will be the growth rate? What are key market trends? What is driving this market? What are the challenges to market growth? Who are the key vendors in this market space? What are the market opportunities and threats faced by key vendors? What are the strengths and weaknesses of each of these key vendors? table Of Contents: 1. Executive Summary 2. List Of Abbreviations 3. Introduction 4. Research Methodology market Research Process research Design research Methodology Global Immunoassay Systems Market 2012 - 2016
  • 2. 5. Scope Of The Report market Overview product Offerings 6. Market Landscape 6.1 Global Immunoassay Systems Market market Size And Forecast 6.2 Market Segmentation enzyme Immunoassay Systems fluorescence Immunoassay Systems chemiluminescence Immunoassay Systems radio Immunoassay Systems nephelometric Immunoassay Systems 6.3 Global Enzyme Immunoassay Systems Market market Size And Forecast 6.4 Five Forces Analysis 7. Geographical Segmentation 8. Vendor Landscape 9. Buying Criteria 10. Market Growth Drivers 11. Drivers And Their Impact 12. Market Challenges 13. Impact Of Drivers And Challenges 14. Market Trends Global Immunoassay Systems Market 2012 - 2016
  • 3. 15. Key Vendor Analysis 15.1 Abbott Laboratories business Overview key Information swot Analysis 15.2 Danaher Corp. business Overview key Information swot Analysis 15.3 Roche Holding Ltd. business Overview key Information swot Analysis 15.4 Siemens Healthcare Diagnostics Inc. business Overview key Information swot Analysis 16. Other Reports In This Series ResearchMoz(http://www.researchmoz.us/) is the one stop online destination to find and buy market research reports & Industry Analysis. We fulfill all your research needs spanning across industry verticals with our huge collection of market research reports. We provide our services to all sizes of organizations and across all industry verticals and markets. Our Research Coordinators have in-depth knowledge of reports as well as publishers and will assist you in making an informed decision by giving you unbiased and deep insights on which reports will satisfy your needs at the best price. Contact: M/s Sheela, 90 State Street, Suite 700, Albany NY - 12207 United States Tel: +1-518-618-1030 USA - Canada Toll Free 866-997-4948 Email: sales@researchmoz.us Website: http://www.researchmoz.us/ Global Immunoassay Systems Market 2012 - 2016